Morgan Stanley’s ENvue Medical Inc FEED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8K Buy
+10,000
New +$21.7K ﹤0.01% 6659
2025
Q4
Sell
-1,000
Closed -$5.64K 8384
2025
Q3
$5.64K Buy
1,000
+897
+871% +$6.75K ﹤0.01% 7058
2025
Q2
$954 Sell
103
-1,259
-92% -$37.5K ﹤0.01% 7339
2025
Q1
$46.4K Buy
+1,362
New +$62.5K ﹤0.01% 6293
2024
Q2
Hold
0
-$9 7928
2024
Q1
Hold
0
7775
2023
Q4
Hold
0
7751
2023
Q3
Hold
0
7538
2023
Q2
Hold
0
7559
2023
Q1
Hold
0
7624
2022
Q4
Hold
0
7734
2022
Q3
Hold
0
7816
2022
Q2
Hold
0
7910
2022
Q1
Sell
-50
Closed -$94.4K 8060
2021
Q4
$115K Buy
50
+41
+456% +$122K ﹤0.01% 6354
2021
Q3
$40K Buy
+9
New +$39.9K ﹤0.01% 6810
2019
Q4
Hold
0
6717
2019
Q3
Hold
0
6709
2019
Q2
Hold
0
6705
2019
Q1
Hold
0
6664
2018
Q3
Hold
0
6763
2018
Q2
Hold
0
6716

Other funds holding FEED

Morgan Stanley's FEED Position: Q1 2026 in Review

Morgan Stanley opened a new position in ENvue Medical Inc (FEED) in Q1 2026: 10,000 shares worth $23.8K. The stake represents ﹤0.01% of the portfolio and ranks #6659 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in FEED as recently as Q3 2025.

Morgan Stanley first reported a position in FEED in Q3 2021 and has held it in 6 quarters since. The position peaked at $115K in Q4 2021. 13 funds tracked by Wall St. Rank hold FEED as of Q1 2026.

  • Morgan Stanley held 10,000 shares of ENvue Medical Inc worth $23.8K as of Q1 2026.
  • ENvue Medical Inc was a new Morgan Stanley position in Q1 2026.
  • ENvue Medical Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6659 holding.
  • Morgan Stanley first reported a position in ENvue Medical Inc in Q3 2021 and has held it in 6 quarters since.
  • Morgan Stanley's ENvue Medical Inc position peaked at $115K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.